Results 1 to 10 of about 487,201 (201)
Efficacy and Safety of Low-Dose Aspirin in Polycythemia Vera
BACKGROUND: The use of aspirin for the prevention of thrombotic complications in polycythemia vera is controversial. METHODS: We enrolled 518 patients with polycythemia vera, no clear indication for aspirin treatment, and no contraindication to such ...
Roberto Marchioli +2 more
exaly +2 more sources
Ruxolitinib Versus Standard Therapy for the Treatment of Polycythemia Vera [PDF]
BACKGROUND Ruxolitinib, a Janus kinase (JAK) 1 and 2 inhibitor, was shown to have a clinical benefit in patients with polycythemia vera in a phase 2 study.
Alessandro Maria Vannucchi +2 more
exaly +4 more sources
Some of the next articles are maybe not open access.
Bone-Marrow Responses in Polycythemia Vera
New England Journal of Medicine, 1974A A Axelrad, J F Prchal
exaly
PSYCHOSIS IN POLYCYTHEMIA VERA
The Journal of Nervous and Mental Disease, 1952openaire +2 more sources
Cardiovascular Events and Intensity of Treatment in Polycythemia Vera
New England Journal of Medicine, 2013Elena Maria Elli +2 more
exaly
Surgical Implications of Polycythemia Vera °
Annals of Surgery, 1960W T, FITTS +3 more
openaire +2 more sources
Polycythemia Vera: Stem-Cell and Probable Clonal Origin of the Disease
New England Journal of Medicine, 1976L Steinmann +2 more
exaly
Increased Incidence of Acute Leukemia in Polycythemia Vera Associated With Chlorambucil Therapy
New England Journal of Medicine, 1981Murray N Silverstein +2 more
exaly
Current Management Strategies for Polycythemia Vera and Essential Thrombocythemia
Blood Reviews, 2020Alessandro Maria Vannucchi +1 more
exaly

